Literature DB >> 30279098

Immunosuppressive burden and risk factors of infection in primary childhood nephrotic syndrome.

Khalid Alfakeekh1, Mohammed Azar2, Banan Al Sowailmi3, Saja Alsulaiman4, Salwa Al Makdob5, Aamir Omair6, Esam Albanyan7, Manal Saleh Bawazeer8.   

Abstract

INTRODUCTION: Patients with primary childhood nephrotic syndrome (PCNS) develop alterations in their cellular and humoral immunity that predisposes them to the development of infection, and lead them to have frequent relapses. Also, infection could be significantly enhanced by immunosuppressive agents. This study aims to estimate the immunosuppressive burden, rate of infection and identify possible risk factors in PCNS requiring hospitalization.
METHODOLOGY: A cross-sectional study of hospitalized children≤14years of age diagnosed with PCNS in King Abdul-Aziz Medical City, Riyadh from January 2003 to December 2013. RESULT: Out of 111 patients admitted with PCNS, 84 (76%) had both minor and major types of infection. Upper respiratory tract infection (URTI) was the most predominant type (n=44, 52%). Among the major types of infection, urinary tract infection (UTI) was the most common infection (n=21, 25%) followed by pneumonia (n=17, 20%) then cellulitis (n=6, 6%). Infection in children who received a higher annual cumulative dose of steroids (CDS) strikingly had a higher rate of infection in comparison to those who received lower CDS (p<0.01). Moreover, those who received primary and secondary immunosuppressant's had 100% infection rate.
CONCLUSION: About half of infection encountered by PCNS patients were URTI followed by UTI and pneumonia. Higher annual CDS, combination of primary and secondary immunosuppressants were the highest independent risk factors for infection. Among the infection, URTI was considered as the predominant entity whereas among the major infection, UTI was predominant followed by pneumonia then cellulitis.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cumulative dose of steroids; Primary childhood nephrotic syndrome; Upper respiratory tract infection; Urinary tract infection

Mesh:

Substances:

Year:  2018        PMID: 30279098     DOI: 10.1016/j.jiph.2018.09.006

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  12 in total

1.  Steroid Sensitive Nephrotic Syndrome: Revised Guidelines.

Authors:  Aditi Sinha; Arvind Bagga; Sushmita Banerjee; Kirtisudha Mishra; Amarjeet Mehta; Indira Agarwal; Susan Uthup; Abhijeet Saha; Om Prakash Mishra
Journal:  Indian Pediatr       Date:  2021-03-20       Impact factor: 1.411

2.  The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome.

Authors:  Yuta Inoki; Kentaro Nishi; Mai Sato; Masao Ogura; Koichi Kamei
Journal:  Pediatr Nephrol       Date:  2022-06-24       Impact factor: 3.714

3.  AGREEing on clinical practice guidelines for idiopathic steroid-sensitive nephrotic syndrome in children.

Authors:  Khalid Abdulaziz Alhasan; Reem Al Khalifah; Majed Aloufi; Weiam Almaiman; Muddathir Hamad; Naif Abdulmajeed; Abdullah Al Salloum; Jameela A Kari; Muneera AlJelaify; Rolan K Bassrawi; Turki Al Hussain; Adi Alherbish; Abdulhadi Al Talhi; Mohamad-Hani Temsah; Sidharth Kumar Sethi; Rupesh Raina; Reny Joseph; Yasser Sami Amer
Journal:  Syst Rev       Date:  2021-05-10

4.  Transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of pediatric nephrotic syndrome: a pilot study.

Authors:  Kumail Merchant; Stavros Zanos; Timir Datta-Chaudhuri; Clifford S Deutschman; Christine B Sethna
Journal:  Bioelectron Med       Date:  2022-01-26

5.  Disease-Associated Systemic Complications in Childhood Nephrotic Syndrome: A Systematic Review.

Authors:  Dany Hilmanto; Fitriana Mawardi; Ayuningtyas S Lestari; Ahmedz Widiasta
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-02-25

6.  Infection-Related Acute Care Events among Patients with Glomerular Disease.

Authors:  Dorey A Glenn; Candace D Henderson; Michelle O'Shaughnessy; Yichun Hu; Andrew Bomback; Keisha Gibson; Larry A Greenbaum; Jarcy Zee; Laura Mariani; Ronald Falk; Susan Hogan; Amy Mottl
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-20       Impact factor: 8.237

Review 7.  Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review.

Authors:  Jiao Lin; Li-Min Huang; Jing-Jing Wang; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2021-06-01       Impact factor: 2.764

8.  Expression of miRNA-223 and NLRP3 gene in IgA patients and intervention of traditional Chinese medicine.

Authors:  Liqi Li; Zhaoyong Gong; Piliang Xue; Dandan Wang; Meixiu Xu; Shumei Sui; Liya Li
Journal:  Saudi J Biol Sci       Date:  2020-04-25       Impact factor: 4.219

9.  Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome.

Authors:  Manish Kumar; Jaypalsing Ghunawat; Diganta Saikia; Vikas Manchanda
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

10.  Risk Factors for Poor Prognosis of Severe Infection in Children With Idiopathic Nephrotic Syndrome: A Double-Center, Retrospective Study.

Authors:  Hengci Zhang; Shiyuan Qiu; Cheng Zhong; Lin Shi; Jiacheng Li; Tao Zhang; Xiaoping Zhu; Mo Wang
Journal:  Front Pediatr       Date:  2021-07-14       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.